Aeva CEO Sells 488,160 Shares for $6.3 Million on January 2, 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 10 2026
0mins
Source: NASDAQ.COM
- Large Transaction: Aeva Technologies CEO Soroush Salehian Dardashti sold 488,160 shares on January 2, 2026, for approximately $6.3 million at $12.96 per share, indicating a potential reduction in confidence in the stock.
- Stake Reduction: This sale reduced Dardashti's direct ownership to 11.61%, leaving him with 1,831,199 shares, reflecting a decrease in available selling capacity after a period of sustained selling since March 2025.
- Market Reaction: Following Dardashti's sale, Aeva's stock price surged due to a deal with Nvidia, highlighting market optimism regarding its future prospects, particularly in the autonomous driving sector.
- Technological Advancement: Aeva's FMCW sensing technology is crucial across various industries, especially in autonomous driving and AI applications, suggesting that Dardashti's sale may be more about locking in gains than a negative outlook on the company's future.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on AEVA
Wall Street analysts forecast AEVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AEVA is 23.89 USD with a low forecast of 18.55 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 14.400
Low
18.55
Averages
23.89
High
33.00
Current: 14.400
Low
18.55
Averages
23.89
High
33.00
About AEVA
Aeva Technologies, Inc. is engaged in the design, manufacturing and sale of LiDAR sensing systems and related perception and autonomy-enabling software solutions serving customers in automotive, industrial, and other markets. The Company, through its frequency modulated continuous wave (FMCW) sensing technology, enables the adoption of LiDAR across broad applications. Its sensing and perception technology integrates all key LiDAR components onto a silicon photonics chip in a compact module. Its products include Aeries II, is a 4D LiDAR solution, consisting of its 4D LiDAR sensing system with embedded software designed for automotive grade production across passenger car, trucking, and mobility applications; Atlas, is its FMCW 4D LiDAR with simultaneous velocity and range detection targeted for the automotive market, and Atlas Ultra, is a 4D LiDAR sensor built to meet the performance demands of SAE Level 3 and 4 automated driving systems in passenger and commercial vehicles.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aeva to Participate in Oppenheimer Conference
- Investor Event: Aeva management will participate in the Oppenheimer 11th Annual Emerging Growth Conference on February 3, 2026, providing an opportunity for engagement with institutional investors to enhance the company's visibility and credibility.
- Technological Vision: Aeva aims to accelerate autonomy across various sectors, including automated driving, manufacturing automation, and smart infrastructure, showcasing its leadership in future technologies.
- Product Advantage: Aeva's 4D LiDAR sensors uniquely detect velocity and position simultaneously, enabling automated devices like vehicles and robots to make more intelligent and safer decisions, thereby enhancing competitiveness in the industry.
- Market Positioning: By collaborating with Oppenheimer, Aeva seeks to further solidify its position in the automation and smart device market, attracting more investments to support its technology development and market expansion.
Continue Reading
Valneva SE Withdraws Chikungunya Vaccine Applications, Shares Drop 7.7%
- Vaccine Withdrawal: Valneva SE has withdrawn its BLA and IND applications for the IXCHIQ Chikungunya vaccine due to an FDA suspension and review of new serious adverse events, leading to a 7.7% drop in pre-market trading to $9.29, indicating market concerns over its product prospects.
- Market Decline: U.S. stock futures are broadly lower, with Dow futures falling around 700 points, reflecting investor caution regarding economic outlook, which may impact overall market sentiment and exacerbate volatility in other stocks.
- Other Stock Movements: Shares of Rezolve AI PLC and POET Technologies Inc fell 15% and 11.2% respectively in pre-market trading, indicating widespread investor apprehension towards tech stocks, potentially prompting a reassessment of risk appetite.
- Tesla Update: Tesla's stock fell 2.7% to $425.75 in pre-market trading, despite CEO Elon Musk confirming that vehicles equipped with the AI4 chip will achieve unsupervised autonomous driving, suggesting insufficient market confidence in the electric vehicle sector.
Continue Reading